Mark Hazeltine

Mark Hazeltine

former Chief Business OfficeratExagen· In proxies 2022–2023

Pay in FY2023+1% from the year before · Exagen stock -17.1% the same year

Mark Hazeltine was paid $1.1M in FY2023 (Dec), up 1%. Exagen stock fell 17.1% that year.

Pay$100 in the stock at the end of FY21 → $17
Pay is from the Summary Compensation Table of each Exagen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ExagenPublic company · 4 yr
    • former Chief Business Officer2022 – Present · 4 yrStock in role -24%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?